Business
Proposed Director Appointments & Update
Proposed Director Appointments & Update.
About this update from Tsp Advanced Technologies Plc
[{"type":"text","content":"\n\n18 September 2023\n \nTruSpine Technologies plc\n(\"TruSpine\" or the \"Company\")\n \nProposed Director Appointments & Update\nTruSpine Technologies plc, (AQSE: TSP) the medical device company focused on the development of its pioneering \"screwless,\" spinal (vertebral) stabilisation systems announces the proposed appointments of Victoria Sena and Samuel Ogunsalu as Non-Executive Directors of the Company, subject to standard regulatory due diligence.\nProposed Director Appointments\nVictoria Sena founded Cherrybank Consulting Limited in 2019 to assist clients in the areas of governance, operations, risk, and compliance. Previously Victoria spent eight years at the Bank of England in the authorisations, banking, and insurance divisions, and completed a secondment to the Treasury Committee of the House of Commons. After moving to the private sector Victoria served as a Group Risk Manager for an international insurance group, before becoming Chief Operating Officer of a boutique investment manager where she was an FCA Approved Person. She is a Chartered Member of the Chartered Institute of Securities and Investments and holds degrees from Oxford University and the London School of Economics and Political Science.\nSamuel Ogunsalu has over 20 years' experience in technology commercialisation, licensing, and business development. He has executed a wide number of transactions ranging from negotiating licences and M&As, to transformational technology partnerships with companies such as Merck, GSK, Pharmacia (merged with Pfizer) and Abbott (now AbbVie) as well as helping to establish preclinical research programmes with a number of industrial partners and set up joint ventures, start-ups, and spinout companies to develop novel technologies. Samuel was previously Chief Business Officer & Director of an oncology company and Chief Commercial Officer of an AIM listed biotech company. Prior to that he has held a number of positions across technology business units connected with Queen Mary College, London, as well as other roles in which he has advised private and listed companies in both the UK and the USA. He started his professional career as a pilot plant engineer at Imperial College, London, followed by scientific research at University College London, before moving into business & commercial development....